Alexandre Destère

495 total citations
40 papers, 257 citations indexed

About

Alexandre Destère is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Alexandre Destère has authored 40 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 9 papers in Infectious Diseases and 7 papers in Epidemiology. Recurrent topics in Alexandre Destère's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Drug-Induced Adverse Reactions (4 papers). Alexandre Destère is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Drug-Induced Adverse Reactions (4 papers). Alexandre Destère collaborates with scholars based in France, Norway and Netherlands. Alexandre Destère's co-authors include Pierre Marquet, Jean‐Baptiste Woillard, Milou‐Daniel Drici, Alexandre O. Gérard, Marc Labriffe, Fanny Rocher, Michel Lantéri‐Minet, Caroline Monchaud, Stéphan Ehrmann and Chantal Barin‐Le Guellec and has published in prestigious journals such as International Journal of Molecular Sciences, Antimicrobial Agents and Chemotherapy and Frontiers in Immunology.

In The Last Decade

Alexandre Destère

38 papers receiving 255 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandre Destère France 9 51 37 36 30 30 40 257
P Chan United Kingdom 5 55 1.1× 28 0.8× 10 0.3× 16 0.5× 23 0.8× 6 294
Ádám Kiss Hungary 12 32 0.6× 136 3.7× 26 0.7× 20 0.7× 28 0.9× 19 328
Kristi Krebs Estonia 10 63 1.2× 16 0.4× 9 0.3× 22 0.7× 12 0.4× 20 418
Björn Schniedewind United States 13 59 1.2× 17 0.5× 96 2.7× 45 1.5× 39 1.3× 23 381
Marcos Navares‐Gómez Spain 12 49 1.0× 53 1.4× 7 0.2× 46 1.5× 27 0.9× 35 361
Chadi Abbara France 12 94 1.8× 18 0.5× 34 0.9× 30 1.0× 50 1.7× 58 464
Hyeong-Seok Lim South Korea 10 27 0.5× 46 1.2× 10 0.3× 13 0.4× 21 0.7× 24 302
Isabelle Benz‐de Bretagne France 12 30 0.6× 10 0.3× 15 0.4× 24 0.8× 61 2.0× 32 425
Sofie Velghe Belgium 7 78 1.5× 22 0.6× 18 0.5× 5 0.2× 44 1.5× 8 412
Hari V. Kalluri United States 9 41 0.8× 22 0.6× 29 0.8× 18 0.6× 18 0.6× 15 330

Countries citing papers authored by Alexandre Destère

Since Specialization
Citations

This map shows the geographic impact of Alexandre Destère's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Destère with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Destère more than expected).

Fields of papers citing papers by Alexandre Destère

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Destère. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Destère. The network helps show where Alexandre Destère may publish in the future.

Co-authorship network of co-authors of Alexandre Destère

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Destère. A scholar is included among the top collaborators of Alexandre Destère based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Destère. Alexandre Destère is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gérard, Alexandre O., et al.. (2025). Safety profile of belatacept in a real-life setting: disproportionality analysis of the WHO pharmacovigilance database. BMC Pharmacology and Toxicology. 26(1). 147–147.
2.
Gérard, Alexandre O., et al.. (2025). Evaluating and leveraging large language models in clinical pharmacology and therapeutics assessment: From exam takers to exam shapers. British Journal of Clinical Pharmacology. 1 indexed citations
3.
Teisseyre, Maxime, Alexandre Destère, Marion Crémoni, et al.. (2025). Artificial intelligence-based personalised rituximab treatment protocol in membranous nephropathy (iRITUX): protocol for a multicentre randomised control trial. BMJ Open. 15(4). e093920–e093920.
4.
Capdevila, Xavier, et al.. (2025). Impact of epinephrine on ropivacaine pharmacokinetics in TAP blocks: a randomized controlled trial. Regional Anesthesia & Pain Medicine. rapm–2025. 1 indexed citations
5.
Destère, Alexandre, et al.. (2024). An artificial intelligence algorithm for co‐clustering to help in pharmacovigilance before and during the COVID‐19 pandemic. British Journal of Clinical Pharmacology. 90(5). 1258–1267. 2 indexed citations
6.
Destère, Alexandre, et al.. (2024). Deep dynamic co-clustering of count data streams: application to pharmacovigilance. SPIRE - Sciences Po Institutional REpository. 4(4). 1 indexed citations
7.
Rubera, Isabelle, et al.. (2024). A Plasma Pyrophosphate Cutoff Value for Diagnosing Pseudoxanthoma Elasticum. International Journal of Molecular Sciences. 25(12). 6502–6502. 3 indexed citations
8.
Gérard, Alexandre O., Alexandre Destère, Florence Askénazy, et al.. (2024). Cardiac and metabolic safety profile of antipsychotics in youths: A WHO safety database analysis. Psychiatry Research. 334. 115786–115786. 4 indexed citations
9.
Woillard, Jean‐Baptiste, et al.. (2024). To be or not to be, when synthetic data meet clinical pharmacology: A focused study on pharmacogenetics. CPT Pharmacometrics & Systems Pharmacology. 14(1). 82–94. 2 indexed citations
10.
11.
Gérard, Alexandre O., Alexandre Destère, Michaël Loschi, et al.. (2023). CAR-T Cells and the Kidney: Insights from the WHO Safety Database. BioDrugs. 37(4). 521–530. 7 indexed citations
12.
Gérard, Alexandre O., Alexandre Destère, Florence Askénazy, et al.. (2023). Iatrogenic triggers for anorexia nervosa and bulimia nervosa: A WHO safety database disproportionality analysis. Psychiatry Research. 327. 115415–115415. 2 indexed citations
13.
Destère, Alexandre, et al.. (2023). Tacrolimus population pharmacokinetics in adult heart transplant patients. British Journal of Clinical Pharmacology. 89(12). 3584–3595. 6 indexed citations
14.
Gérard, Alexandre O., et al.. (2023). The Neuropsychiatric Safety Profile of Lasmiditan: A Comparative Disproportionality Analysis with Triptans. Neurotherapeutics. 20(5). 1305–1315. 3 indexed citations
15.
Destère, Alexandre, et al.. (2023). A HPLC-DAD method to facilitate large-scale therapeutic drug monitoring of dalbavancin. Journal of Chromatography B. 1222. 123694–123694. 5 indexed citations
16.
Destère, Alexandre, et al.. (2023). Drug-induced cardiac toxicity and adverse drug reactions, a narrative review. Therapies. 79(2). 161–172. 16 indexed citations
17.
Gérard, Alexandre O., Bruno Giordana, Fanny Rocher, et al.. (2022). Medications as a Trigger of Sleep-Related Eating Disorder: A Disproportionality Analysis. Journal of Clinical Medicine. 11(13). 3890–3890. 9 indexed citations
18.
Gérard, Alexandre O., et al.. (2022). Calcitonin gene-related peptide-targeting drugs and Raynaud’s phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database. The Journal of Headache and Pain. 23(1). 53–53. 30 indexed citations
19.
Destère, Alexandre, et al.. (2022). Optimization of Vancomycin Initial Dose in Term and Preterm Neonates by Machine Learning. Pharmaceutical Research. 39(10). 2497–2506. 25 indexed citations
20.
Gérard, Alexandre O., Bruno Giordana, Fanny Rocher, et al.. (2022). COVID-19 Vaccine-Associated Transient Global Amnesia: A Disproportionality Analysis of the WHO Safety Database. Frontiers in Pharmacology. 13. 909412–909412. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P Chan Breakdown of academic impact, for papers by Ádám Kiss Breakdown of academic impact, for papers by Kristi Krebs Breakdown of academic impact, for papers by Björn Schniedewind Breakdown of academic impact, for papers by Marcos Navares‐Gómez Breakdown of academic impact, for papers by Chadi Abbara Breakdown of academic impact, for papers by Hyeong-Seok Lim Breakdown of academic impact, for papers by Isabelle Benz‐de Bretagne Breakdown of academic impact, for papers by Sofie Velghe Breakdown of academic impact, for papers by Hari V. Kalluri
Rankless by CCL
2026